 |
 |

White Clot SyndromePeripheral Vascular Complications of Heparin Therapy
Jonathan B. Towne, MD;
Victor M. Bernhard, MD;
Clara Hussey, MD;
J. C. Garancis, MD
Arch Surg. 1979;114(4):372-377.
Abstract
 |  |
Heparin sodium-induced thrombosis is insidious and difficult to diagnose. If untreated, it results in death or major amputation. We have treated seven patients with thromboses resulting from platelet aggregation induced by heparin. Four patients had acute arterial ischemia of the lower extremity, venous gangrene developed in two, and one patient had an occluded autogenous vein femoral popliteal bypass in the immediate postoperative period. The platelet count was noticeably reduced in affected patients. White platelet thrombi were noted in four patients, three of whom had acute arterial occlusion. A white thrombus was the cause of immediate failure of a femoral popliteal graft. Electron microscopic examination of these thrombi demonstrated predominantly fibrin platelet aggregates with an occasional entrapped WBC and a rare RBC. All patients receiving heparin therapy must have platelet counts performed regularly. If thrombocytopenia is detected, platelet aggregation studies are indicated. When abnormal platelet aggregation is noted, heparin therapy should be reversed with protamine sulfate and the patient treated with low-molecular-weight dextran and warfarin sodium.
(Arch Surg 114:372-377, 1979)
Author Affiliations
From the Departments of Surgery (Drs Towne and Bernhard) and Pathology (Drs Hussey and Garancis), Medical College of Wisconsin, Milwaukee.
Footnotes
Accepted for publication Dec 27, 1978.
Presented at the 86th annual meeting of the Western Surgical Association, Scottsdale, Ariz, Nov 13, 1978.
Reprint requests to Division of Surgery, Medical College of Wisconsin, 8700 W Wisconsin Ave, Milwaukee, WI 53226 (Dr Towne).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia
Bartholomew
Chest 2005;127:27S-34S.
ABSTRACT
| FULL TEXT
Heparin-Induced Thrombocytopenia: Historical Review
Messmore
CLIN APPL THROMB HEMOST 1999;5:S2-S6.
ABSTRACT
Clinical Aspects of Heparin-Induced Thrombocytopenia and Thrombosis and Other Side Effects of Heparin Therapy
Bick and Frenkel
CLIN APPL THROMB HEMOST 1999;5:S7-S15.
ABSTRACT
Functional Heterogeneity of Antiheparin-Platelet Factor 4 Antibodies: Implications in the Pathogenesis of the HIT Syndrome
Ahmad et al.
CLIN APPL THROMB HEMOST 1999;5:S32-S37.
ABSTRACT
Heparin-Induced Thrombocytopenia
Cummins and Hill
SEMIN CARDIOTHORAC VASC ANESTH 1997;1:349-365.
ABSTRACT
Carotid Endarterectomy and Perioperative Stroke
Perry et al.
PERSPECT VASC SURG ENDOVASC THER 1993;6:15-28.
Heparin-Induced Thrombocytopenia
Sobel
PERSPECT VASC SURG ENDOVASC THER 1992;5:1-27.
Technical Defects as a Cause of Early Graft Failure After Femorodistal Bypass
Stept et al.
Arch Surg 1987;122:599-604.
ABSTRACT
Acute Limb Ischemia Following Aortic Reconstruction: A Preventable Cause of Increased Mortality
Strom et al.
Arch Surg 1984;119:470-473.
ABSTRACT
Heparin-Associated Thrombocytopenia
KING and KELTON
ANN INTERN MED 1984;100:535-540.
ABSTRACT
Heparin and Antithrombin 3
STEIN
Arch Surg 1979;114:980-980.
ABSTRACT
|